Answers are grounded in this paper and cite their sources.
This research explores iron complexes for direct arylation of pyrrole, suggesting a sustainable alternative to palladium.
Biaryl motifs are central in pharmaceutical drug design, yet conventional synthesis via palladium-catalyzed cross-coupling poses increasing sustainability and cost concerns. The study presented herein explores a greener alternative to palladium using iron(II) complexes supported by tetra-aza macrocyclic ligands for direct arylation of pyrrole with phenylboronic acids. Under aerobic conditions, the optimized [Fe²⁺L1(Cl)₂] complex of ligand Me₂Cyclam (L1; 1,8-dimethyl-1,4,8,11-tetraazacyclotetradecane) showed broad substrate compatibility across 23 derivatives, achieving yields up to 66%, and excellent tolerance for functional groups including halides, esters, and strong electron-deficient substituents. Systematic analysis of these results suggests that meta-substitution and mild electron-withdrawing effects favor reactivity, while bulky ortho-steric hindrance suppresses coupling. Mechanistic studies ruled out outer-sphere radical pathways and high-valent iron complexes but do suggest iron(III)-hydroperoxo species as the operative oxidant. Density functional theory (DFT) analysis was carried out on the boronic acid substrates to show that electron-withdrawing substituents enhance the boron electrophilicity and promote the proposed transmetalation step, positioning this step as a key target for mechanistic activation of the substrate. These findings highlight the potential of earth-abundant iron catalysts as sustainable, cost-effective platforms for C-C bond formation in complex molecular scaffolds.
No takes yet. Share an insight, caveat, or question.
Afroz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: